Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

Genetic testing identifies germline mutations, while genomic testing analyzes somatic mutations in tumors, influencing treatment options. Broader testing criteria are expanding access to genetic ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

A review of the distribution of risk estimates from three commonly used genomic assays for breast cancer found that Black women were more likely to have aggressive tumor phenotypes, which contributed ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

Komen(R) , the world's leading breast cancer organization, commends Representative Rick Scarbrough (R-Oak Ridge) and Senator Richard Briggs (R-Knoxville) for introducing legislation that would ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...